1-3 of 3
Daniel J. Zinn
Close
Sort by
Journal Articles

A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility

Erin C. Peckham-Gregory, Rikhia Chakraborty, Michael E. Scheurer, John W. Belmont, Harshal Abhyankar, Amel G. Sengal, Brooks P. Scull, Olive Eckstein, Daniel J. Zinn, Louisa Mayer, Albert Shih, Miriam Merad, D. Williams Parsons, Kenneth L. McClain, Philip J. Lupo, Carl E. Allen
Journal: Blood
Blood (2017) 130 (20): 2229–2232.
https://doi.org/10.1182/blood-2017-08-800565
Published: 2017
Includes: Supplemental data
Journal Articles

Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis

Clinical Trials & Observations Brief Report
Rikhia Chakraborty, Thomas M. Burke, Oliver A. Hampton, Daniel J. Zinn, Karen Phaik Har Lim, Harshal Abhyankar, Brooks Scull, Vijetha Kumar, Nipun Kakkar, David A. Wheeler, Angshumoy Roy, Poulikos I. Poulikakos, Miriam Merad, Kenneth L. McClain, D. Williams Parsons, Carl E. Allen
Journal: Blood
Blood (2016) 128 (21): 2533–2537.
https://doi.org/10.1182/blood-2016-08-733790
Published: 2016
Includes: Supplemental data
Journal Articles

Hydroxyurea: a new old therapy for Langerhans cell histiocytosis

Clinical Trials & Observations
Daniel J. Zinn, Amanda B. Grimes, Howard Lin, Olive Eckstein, Carl E. Allen, Kenneth L. McClain
Journal: Blood
Blood (2016) 128 (20): 2462–2465.
https://doi.org/10.1182/blood-2016-06-721993
Published: 2016